1. Membrane Transporter/Ion Channel
  2. Amino acid Transporter
  3. SLC6A19-IN-4

SLC6A19-IN-4 是一种变构竞争性且具有口服活性的 B0AT1 (SLC6A19) 抑制剂。SLC6A19-IN-4 对人和小鼠的 B0AT1 均具有抑制活性,IC50 值分别为 513 nM 和 295 nM。SLC6A19-IN-4 表现出优异的代谢稳定性。SLC6A19-IN-4 通过对肠道 (减少吸收) 和肾脏 (促进排泄) 中B0AT1 的双重抑制,能显著增加尿液中苯丙氨酸 (Phe) 的排泄并降低血浆 Phe 水平。 SLC6A19-IN-4 可用于苯丙酮尿症 (PKU) 及其他涉及 SLC6 家族转运蛋白疾病的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

SLC6A19-IN-4

SLC6A19-IN-4 Chemical Structure

CAS No. : 2962069-39-0

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

SLC6A19-IN-4 is an allosteric-competitive and orally active BAT1 inhibitor. SLC6A19-IN-4 inhibits both human and mouse BAT1b> with IC50 values of 513 nM and 295 nM, respectively. SLC6A19-IN-4 exhibits excellent metabolic stability. SLC6A19-IN-4 significantly increases urinary phenylalanine (Phe) excretion and reduces plasma Phe levels through dual inhibition of BAT1 in both the intestine (reducing absorption) and kidney (promoting excretion) in vivo. SLC6A19-IN-4 can be used for phenylketonuria (PKU) and other disorders involving SLC6-family transporters research[1].

体外研究
(In Vitro)

SLC6A19-IN-4 (1500-4000 nM) 在表达人源 SLC6A19 和人源 Collectrin 的 Jump-In TI platform 细胞中,增加了对 d5-Phe 摄取的 Km 值而不影响 Vmax 值,表明了其竞争性抑制特性 (Km 值分别为 0.866、5.19、12.1 mM;Vmax 值分别为 337、351、380 μmol/min/mg-protein)[1]
SLC6A19-IN-4 在模拟细胞与小鼠 BAT1 和 ACE2 共表达细胞中 Kd 为 123.1 nM,在模拟细胞与人源 BAT1 和 ACE2 共表达细胞中的 Kd 为 46.98 nM[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

SLC6A19-IN-4 (30 mg/kg,口服,单次给药) 可通过减少肠道苯丙氨酸 (Phe) 吸收、促进尿液排泄,从而降低携带 F263S 纯合突变的雄性 Pahenu2 小鼠的全身 Phe 水平[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Pahenu2 mice (12 weeks) carry a homozygous F263[1]
Dosage: 30 mg/kg
Administration: p.o., once
Result: Had a plasma concentration of 915 ng/ml and 1590 ng/ml at 4 and 8 hours post-dose.
Showed low membrane permeability 24.2 × 10-7 cm/s.
Increased urinary Phe excretion and concomitantly reduced plasma Phe concentrations 4 hours after dosing.
分子量

355.31

Formula

C16H16F3N3O3

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
SLC6A19-IN-4
目录号:
HY-179581
需求量: